Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Elite Health Systems (EHSI) Change in Interest Receivables (2018)

Elite Health Systems' Change in Interest Receivables history spans 3 years, with the latest figure at $2000.0 for Q2 2018.

  • Quarterly results put Change in Interest Receivables at $2000.0 for Q2 2018, changed N/A from a year ago — trailing twelve months through Jun 2018 was $4000.0 (down 90.48% YoY), and the annual figure for FY2019 was $200000.0, changed.
  • Change in Interest Receivables for Q2 2018 was $2000.0 at Elite Health Systems, roughly flat from $2000.0 in the prior quarter.
  • In the past five years, Change in Interest Receivables ranged from a high of $42000.0 in Q4 2015 to a low of -$139000.0 in Q4 2014.
  • The 3-year median for Change in Interest Receivables is $2000.0 (2018), against an average of -$10400.0.
  • Peak annual rise in Change in Interest Receivables hit 130.22% in 2015, while the deepest fall reached 130.22% in 2015.
  • Year by year, Change in Interest Receivables stood at -$139000.0 in 2014, then surged by 130.22% to $42000.0 in 2015, then tumbled by 95.24% to $2000.0 in 2018.
  • According to Business Quant data, Change in Interest Receivables over the past three periods came in at $2000.0, $2000.0, and $42000.0 for Q2 2018, Q1 2018, and Q4 2015 respectively.